Search results for: 'Funding Analysis of Emerging Microelectronics Technologies'

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...

The healthcare industry is undergoing a massive transformation, with a high focus on personalization and patient-centric care. It is embracing digital transformation and becoming more consumer-/patient friendly. The changing socioeconomic landscape, the high prevalence of chronic diseases, the massive COVID-19 pandemic, and the challenge of resourc...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

The human microbiome is made of several microorganisms that reside within and outside the body. These comprise complex and diverse bacteria, archaea, fungi, viruses, and protozoa. They form signature colonies unique to an individual or body part and help maintain general health and wellness. Any disruptions to the naturally occurring healthy microb...

Smart implants are medical devices that incorporate sensors, electronics, and wireless communication technologies to provide unprecedented diagnostic and therapeutic capabilities. In this report, Frost & Sullivan analyzes smart implants with monitoring capabilities that can track different implant types and provide patient health data to clinicia...

Healthcare interoperability, the ability of different healthcare systems and applications to seamlessly exchange and use patient health data, is critical to advanced, precise, and personalized healthcare. Data interoperability is crucial to advanced, precise, and personalized healthcare; however, achieving interoperability has been a significant ch...

Precision diagnosis in today's healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes. By leveraging advanced technol...

29 Jun 2023  |  Global  |  Technology Research

Emerging Landscape of Targeted Protein Degradation Therapeutics

Rapid Technology Advances Bolster a Robust Therapeutic Pipeline

Infographics

×

This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80%...